Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine
about
Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI InhibitorsInsights into HER2 signaling from step-by-step optimization of anti-HER2 antibodiesCurrent and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptorsAntigen-binding site anatomy and somatic mutations in antibodies that recognize different types of antigens.Computational design of a CNT carrier for a high affinity bispecific anti-HER2 antibody based on trastuzumab and pertuzumab Fabs.Predominant structural configuration of natural antibody repertoires enables potent antibody responses against protein antigensExpression and purification of HER2 extracellular domain proteins in Schneider2 insect cells.Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.Natural and man-made V-gene repertoires for antibody discovery.Inhibition of protein-protein interaction of HER2-EGFR and HER2-HER3 by a rationally designed peptidomimetic.Broad epitope coverage of a human in vitro antibody library.Structure-activity relationships of peptidomimetics that inhibit PPI of HER2-HER3.A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays.Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases.A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization.Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions.
P2860
Q26823990-6CD33242-C16B-4A1C-BB9E-2BBE9372DBCAQ27683825-6FE23E82-DED3-4836-928C-719EA3638581Q28086768-552BE877-BD5F-41AB-B9F9-E0DD938B0542Q34191098-B16595CC-B68D-439B-B18C-FB837BA4A32AQ34473476-F47705A5-1765-4144-B962-574C5662DA4AQ35707409-ACC26EAA-46D6-4112-90AA-323DF24BCB55Q35771539-2A1B3104-DBB4-4993-BFC0-4DA28595BCE1Q36171074-514187DF-D38E-421E-BA9C-430341A5D5CBQ36401413-0B4D365E-A367-4158-B273-7D9F6D4463FEQ36610755-D6947EEC-06DA-4F99-A6E7-B6B49CC0AA5EQ37589828-2A440FB1-7FB6-47D3-8458-D3E307866C89Q37721805-07C58237-5432-46D7-B47B-DB0D0C5B5182Q38642011-AAAC88E8-A1FA-4BC9-8214-B269F287FDD4Q41953134-03B5142C-F54E-45B0-9102-7D1C046F24BCQ44114723-DC83327E-BA87-4A5B-A3BD-A6548B2A70B8Q47996245-2F8C182F-3A83-4453-8609-6D3F7805BD02
P2860
Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structure of the complex betwe ...... ins from tryptophan and serine
@ast
Structure of the complex betwe ...... ins from tryptophan and serine
@en
Structure of the complex betwe ...... ins from tryptophan and serine
@nl
type
label
Structure of the complex betwe ...... ins from tryptophan and serine
@ast
Structure of the complex betwe ...... ins from tryptophan and serine
@en
Structure of the complex betwe ...... ins from tryptophan and serine
@nl
prefLabel
Structure of the complex betwe ...... ins from tryptophan and serine
@ast
Structure of the complex betwe ...... ins from tryptophan and serine
@en
Structure of the complex betwe ...... ins from tryptophan and serine
@nl
P2093
P1476
Structure of the complex betwe ...... ins from tryptophan and serine
@en
P2093
Andreas Lingel
Gabriele Schaefer
Robert D Fisher
Sachdev S Sidhu
Sara Birtalan
P304
P356
10.1016/J.JMB.2010.07.027
P407
P577
2010-09-10T00:00:00Z